Publications by authors named "J Tulio Arredondo"

Confronting environments with low relative humidity is one of the main challenges faced by insects with expanding distribution ranges. (the Mexican fruit fly) has evolved to cope with the variable conditions encountered during its lifetime, which allows it to colonise a wide range of environments. However, our understanding of the mechanisms underpinning the ability of this species to confront environments with low relative humidity is incomplete.

View Article and Find Full Text PDF

Introduction: Although several studies report that the robotic approach is more costly than laparoscopy, the cost-effectiveness of robotic distal pancreatectomy (RDP) over laparoscopic distal pancreatectomy (LDP) is still an issue. This study evaluates the cost-effectiveness of the RDP and LDP approaches across several Spanish centres.

Methods: This study is an observational, multicenter, national prospective study (ROBOCOSTES).

View Article and Find Full Text PDF

Background: Neoadjuvant chemotherapy is increasingly used to treat locally advanced (T3-4 Nx-2 M0) colon cancer due to its potential advantages over the standard approach of upfront surgery. The primary objective of this systematic review and meta-analysis was to analyse data from comparative studies to assess the impact of neoadjuvant chemotherapy on oncological outcomes.

Methods: A systematic review was conducted by searching the MEDLINE and Scopus databases.

View Article and Find Full Text PDF
Article Synopsis
  • Colon cancer is becoming more common in younger people, and treatment usually involves surgery and chemotherapy; however, neoadjuvant chemotherapy is being tested for its potential to improve survival rates.
  • This study is a randomized clinical trial that will compare two treatment groups: one receiving neoadjuvant chemotherapy, surgery, and adjuvant chemotherapy, and the other getting surgery followed by adjuvant chemotherapy.
  • The main goal is to see if neoadjuvant chemotherapy leads to better survival outcomes within two years, while also looking at other factors like tumor response and side effects.
View Article and Find Full Text PDF